Literature DB >> 3510728

Expression of Lewisa, Lewisb, X, and Y blood group antigens in human colonic tumors and normal tissue and in human tumor-derived cell lines.

J Sakamoto, K Furukawa, C Cordon-Cardo, B W Yin, W J Rettig, H F Oettgen, L J Old, K O Lloyd.   

Abstract

Serological and immunopathological analysis of the expression of Lea, Leb, X, and Y blood group antigens on cell lines and tissues was performed using a panel of mouse monoclonal antibodies. The distribution of the antigens was determined on 155 malignant tumor cell lines of various types and 10 short term cultures of normal fibroblasts and kidney cells. Among colon cancers, all four blood group antigens were expressed on the majority of cell lines. On lung, breast, bladder, and ovarian cancer cell lines, X and Y antigens were the main specificities found, whereas few of the renal and hematopoietic tumor cell lines demonstrated any of the four blood group antigens. No blood group antigens could be detected on astrocytoma or melanoma cell lines. The expression of the antigens was also analyzed on frozen sections of colon carcinoma and adjacent normal colon tissue from 42 patients using the immunoperoxidase method. Lea and X were detected throughout the normal colon and on most colonic tumors. In poorly differentiated colon cancer and in metastatic cancer, decrease of Lea antigen was observed. Leb and Y expression was observed in only 20-45% of normal tissue samples but in almost all colonic carcinoma tissues. A selected number of tumor and normal specimens from patients whose secretor status was known were examined in more detail. Both the staining of the tissues and the reactivity of blood group glycolipids from the same specimens were determined. These studies confirmed the above findings and demonstrated the unexpected ability of tumors of nonsecretors to express Leb and/or Y antigens. In such individuals, in whom the expression of Leb and Y antigens in normal tissues is absent or minimal, these antigens provide possible targets for immunodiagnosis and therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510728

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  68 in total

1.  Gastric MUC5AC and MUC6 are large oligomeric mucins that differ in size, glycosylation and tissue distribution.

Authors:  Henrik Nordman; Julia R Davies; Gert Lindell; Carme de Bolós; Francisco Real; Ingemar Carlstedt
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

Review 2.  The chemistry and immunochemistry of blood group A, B, H, and Lewis antigens: past, present and future.

Authors:  K O Lloyd
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

Review 3.  Chimeric antigen receptor T cell therapies for acute myeloid leukemia.

Authors:  Bin Gu; Jianhong Chu; Depei Wu
Journal:  Front Med       Date:  2020-12-01       Impact factor: 4.592

4.  Quantitative interrelations of Lewis antigens in normal mucosa and transitional cell bladder carcinomas.

Authors:  C Limas
Journal:  J Clin Pathol       Date:  1991-12       Impact factor: 3.411

5.  Establishment of a transplantable carcinoma arising from the intrahepatic bile duct in Syrian golden hamsters.

Authors:  T Fukahori; T Tomioka; K Inoue; Y Tajima; T Tsunoda; T Kanematsu
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

6.  The recognition of cancer-associated fucosylated antigens in colorectal cancer by a novel monoclonal antibody, YB-2.

Authors:  H Naitoh; S Yazawa; T Asao; T Nakajima; J Nakamura; S Takenoshita; Y Nagamachi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

7.  Adoptive T-Cell Therapy for Solid Tumors.

Authors:  Oladapo Yeku; Xinghuo Li; Renier J Brentjens
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

8.  Specificity analysis of blood group Lewis-y (Le(y)) antibodies generatedagainst synthetic and natural Le(y) determinants.

Authors:  K Kitamura; E Stockert; P Garin-Chesa; S Welt; K O Lloyd; K L Armour; T P Wallace; W J Harris; F J Carr; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  Lewis y antigen is expressed in oral squamous cell carcinoma cell lines and tissues, but disappears in the invasive regions leading to the enhanced malignant properties irrespective of sialyl-Lewis x.

Authors:  Hiroshi Hotta; Kazunori Hamamura; Kyoko Yamashita; Hidenobu Shibuya; Noriyo Tokuda; Noboru Hashimoto; Keiko Furukawa; Noriyuki Yamamoto; Hisashi Hattori; Shinya Toyokuni; Minoru Ueda; Koichi Furukawa
Journal:  Glycoconj J       Date:  2012-12-15       Impact factor: 2.916

10.  Glycan array analysis of the antigen repertoire targeted by tumor-binding antibodies.

Authors:  Jeffrey C Gildersleeve; Baomei Wang; Samuel Achilefu; Zhude Tu; Mai Xu
Journal:  Bioorg Med Chem Lett       Date:  2012-09-24       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.